What Glow Actually Is
Skin luminosity is the visible result of at least three separate biological processes occurring simultaneously in different tissue layers.
Dermal hydration. When the dermis — the layer beneath the epidermis — is well hydrated, the skin has a fullness and translucency that scatters light with Vermeer's quality. This is not surface moisture. It is the water content of the extracellular matrix, the structural scaffolding between cells. Hyaluronic acid (HA) is the primary water-binding molecule in this matrix. As we age, the skin's natural HA content decreases and the matrix loses its capacity to retain water (Bukhari et al., 2018). The result is skin that looks flat regardless of how well-hydrated the surface appears.
Fibroblast activity. Dermal fibroblasts produce collagen, elastin, and extracellular matrix components. When active, the tissue has structural density and a light-processing quality that reads as glow. When fibroblast activity declines — which begins progressively from the mid-twenties — the tissue becomes optically thinner and light passes through rather than scattering from within (Rittié & Fisher, 2015).
Surface texture. The skin's outer surface scatters light differently depending on texture uniformity. Rough texture, enlarged pores, and surface pigmentation cause diffuse, uneven scatter. Even-textured, well-hydrated skin reflects light more directionally — which the eye reads as radiance.
These three mechanisms operate at different tissue depths, respond to different interventions, and cannot substitute for each other.
Why Topical Skincare Reaches Only One of Them
Topical skincare acts at the epidermal level. The epidermis is, by design, a barrier — it evolved to keep things out. Topical products interact primarily with the stratum corneum and upper epidermis.
Topical hyaluronic acid hydrates the skin surface but cannot meaningfully reach the dermis. A 2025 review in Biomolecules confirmed that high molecular weight HA — the predominant form in topical products — provides surface hydration and anti-inflammatory effects but does not penetrate to the dermal layer where luminosity is produced. Low molecular weight HA penetrates slightly deeper but still does not achieve the dermal concentrations required for tissue rehydration (Papakonstantinou et al., 2025).
This is why a patient applying HA serum twice daily while still looking dull is not doing anything wrong. The product is performing as designed. The dermis is structurally inaccessible from the surface.
Topical vitamin C, retinoids, and peptides contribute to surface texture improvement and some stimulation of the uppermost dermis. They are useful. They maintain the skin barrier and improve surface quality — the third luminosity mechanism. They do not address the first two.
Injectable Skin Boosters: Addressing Dermal Hydration Directly
The direct intervention for dermal hydration is injectable HA placed into the dermis itself. Skin boosters — Rejuran, Juvelook, Skin Vive — use low-viscosity HA formulations designed to spread through the dermal tissue plane rather than creating focal volume.
A 2025 systematic review and meta-analysis in the Journal of Cosmetic Dermatology examined HA-based injectable products across outcome measures including skin hydration, elasticity, and luminosity. The review found statistically significant improvements across all measures following injectable HA treatment — outcomes that topical application could not replicate (Zhou & Yu, 2025).
The mechanism: HA placed in the dermis binds water at that tissue level, expanding the extracellular matrix and restoring the hydration that subsurface light scattering requires. It also interacts with dermal cells through surface receptors (CD44 and RHAMM), stimulating fibroblast signalling and contributing to collagen production beyond simple hydration (Garantziotis & Savani, 2019).
The clinical differentiation between products matters. Polynucleotides (PDRN) — the active component in Rejuran — communicate directly with fibroblasts to stimulate extracellular matrix repair. Their mechanism is biological signalling, not water binding. Juvelook adds dilute poly-D,L-lactic acid (PDLLA), a biostimulator extending the collagen-stimulating effect. These are not interchangeable products. The clinical selection depends on whether the primary concern is hydration, regeneration, or stimulation — often a combination.
Energy Devices: Reactivating Fibroblasts
Fibroblast activity declines with age, UV exposure, and cumulative tissue stress. The result is reduced collagen production, a thinner and less optically dense dermis, and the flat quality patients describe as tired skin.
Topical products cannot meaningfully reactivate fibroblasts at the required depth. The interventions that do are energy-based: radiofrequency (RF), high-intensity focused ultrasound (HIFU), and laser.
The mechanism is controlled thermal stimulus. Each modality delivers energy to a specific tissue depth, creating a controlled injury response. Fibroblasts respond by upregulating collagen synthesis and proliferating. A 2024 review in the International Journal of Molecular Sciences confirmed that exposure of human dermal fibroblasts to photobiomodulation significantly increases procollagen secretion and decreases matrix metalloproteinase (MMP) expression — the enzymes that break down collagen (Leyane et al., 2024). RF produces the same fibroblast response through resistive heating rather than photonic energy.
RF microneedling — Potenza — delivers RF energy directly into the dermis at controlled depth, producing uniform fibroblast stimulus across the treatment zone. HIFU reaches the SMAS layer below the dermis, producing structural lift in addition to dermal remodelling. Fractional laser addresses the upper dermis and epidermis simultaneously, improving surface texture while stimulating the papillary dermis.
These are different tools with different depth profiles and different indications. For pure glow and skin quality improvement without structural concerns, RF microneedling is frequently the most direct choice. For combined lift and quality, HIFU sequenced with a skin booster is the logical pairing.
The Clinical Bottom Line
If luminosity is the goal, the questions to ask are:
Are we addressing dermal hydration or surface hydration? These are different interventions operating at different depths and should not be conflated.
Are we reactivating fibroblasts? This requires an energy device. A treatment plan without RF, HIFU, or laser is not addressing fibroblast activity.
What is the sequence? Energy devices before skin boosters in most cases — the controlled injury response from the device potentiates the effect of injectable products placed into the recovering tissue.
What is the maintenance interval? Dermal HA is metabolised over months. Collagen remodelling develops over three to six months and requires periodic reinforcement. A single treatment produces a temporary result. A protocol produces a lasting one.
Skincare is not useless. A compromised skin barrier accelerates dermal deterioration and reduces the efficacy of in-clinic treatment. It maintains what exists. It cannot rebuild what has been lost at depth.
The budget spent on high-end serums would, in many cases, produce more visible and lasting luminosity if redirected toward one well-planned clinical protocol per year.
That is not a comfortable conclusion for the skincare industry. It is what the evidence shows.
For clinical assessments and consultation in Seoul: itsdrbock.com
References
Bukhari, S. N. A., Roswandi, N. L., Waqas, M., Habib, H., Hussain, F., Khan, S., Sohail, M., Ramli, N. A., Thu, H. E., & Hussain, Z. (2018). Hyaluronic acid, a promising skin rejuvenating biomedicine: A review of recent updates and pre-clinical and clinical investigations on cosmetic and nutricosmetic effects. International Journal of Biological Macromolecules, 120(B), 1682–1695. https://doi.org/10.1016/j.ijbiomac.2018.09.188
Garantziotis, S., & Savani, R. C. (2019). Hyaluronan biology: A complex balancing act of structure, function, location and context. Matrix Biology, 78–79, 1–10. https://doi.org/10.1016/j.matbio.2019.02.002
Leyane, T. S., Jere, S. W., & Houreld, N. N. (2024). Photobiomodulation in fibroblasts: From light to healing through molecular pathways. International Journal of Molecular Sciences, 25(8), 4483. https://doi.org/10.3390/ijms25084483
Papakonstantinou, E., Roth, M., & Karakiulakis, G. (2025). Hyaluronic acid in topical applications: The various forms and biological effects of a hero molecule in the cosmetics industry. Biomolecules, 15(12), 1656. https://doi.org/10.3390/biom15121656
Rittié, L., & Fisher, G. J. (2015). Natural and sun-induced aging of human skin. Cold Spring Harbor Perspectives in Medicine, 5(1), a015370. https://doi.org/10.1101/cshperspect.a015370
Zhou, R., & Yu, M. (2025). The effect of local hyaluronic acid injection on skin aging: A systematic review and meta-analysis. Journal of Cosmetic Dermatology, 24(1), e16760. https://doi.org/10.1111/jocd.16760
